The work of Takahashi et al. has demonstrated a key role of TRPA1 in promoting resistance to ROS-producing chemotherapies and oxidative stress tolerance in breast cancer cells via ROS-mediated TRPA1 activation and Ca2+-CaM/PYK2 signalling pathway [117] (Table 2 and Figure 1). This evidence concerns the gene TRPA1 and breast carcinoma.